Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy

[1] Ervasti JM(1993)A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin J Cell Biol 122 809-823

[2] Campbell KP(1993)Dystrophin protects the sarcolemma from stresses developed during muscle contraction Proc Natl Acad Sci U S A 90 3710-3714

[3] Petrof BJ(2000)The dystrophin complex forms a mechanically strong link between the sarcolemma and costameric actin J Cell Biol 150 1209-1214

[4] Rybakova IN(1997)Animal models for muscular dystrophy show different patterns of sarcolemmal disruption J Cell Biol 139 375-385

[5] Patel JR(2010)Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis and pharmacological and psychosocial management Lancet Neurol 9 77-93

[6] Ervasti JM(1991)Population frequencies of inherited neuromuscular diseases—a world survey Neuromuscul Disord 1 19-29

[7] Straub V(2007)Pathophysiology of duchenne muscular dystrophy: current hypotheses Pediatr Neurol 36 1-7

[8] Bushby K(2012)The paradox of muscle hypertrophy in muscular dystrophy Phys Med Rehabil Clin N Am 23 149-172

[9] Emery AEH(2003)Origins and early descriptions of “Duchenne Muscular Dystrophy” Muscle Nerve 28 402-422

[10] Deconinck N(2007)Cardiomyopathy of Duchenne muscular dystrophy: pathogenesis and prospect of membrane sealants as a new therapeutic approach Expert Rev Cardiovasc Ther 5 99-109

[1] Ervasti JM(1993)A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin J Cell Biol 122 809-823

[2] Campbell KP(1993)Dystrophin protects the sarcolemma from stresses developed during muscle contraction Proc Natl Acad Sci U S A 90 3710-3714

[3] Petrof BJ(2000)The dystrophin complex forms a mechanically strong link between the sarcolemma and costameric actin J Cell Biol 150 1209-1214

[4] Rybakova IN(1997)Animal models for muscular dystrophy show different patterns of sarcolemmal disruption J Cell Biol 139 375-385

[5] Patel JR(2010)Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis and pharmacological and psychosocial management Lancet Neurol 9 77-93

[6] Ervasti JM(1991)Population frequencies of inherited neuromuscular diseases—a world survey Neuromuscul Disord 1 19-29

[7] Straub V(2007)Pathophysiology of duchenne muscular dystrophy: current hypotheses Pediatr Neurol 36 1-7

[8] Bushby K(2012)The paradox of muscle hypertrophy in muscular dystrophy Phys Med Rehabil Clin N Am 23 149-172

[9] Emery AEH(2003)Origins and early descriptions of “Duchenne Muscular Dystrophy” Muscle Nerve 28 402-422

[10] Deconinck N(2007)Cardiomyopathy of Duchenne muscular dystrophy: pathogenesis and prospect of membrane sealants as a new therapeutic approach Expert Rev Cardiovasc Ther 5 99-109